Interleukin 5 and phenotypically altered eosinophils in the blood of patients with the idiopathic hypereosinophilic syndrome.

The Idiopathic Hypereosinophilic Syndrome

1982 • 842 citations

Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3.

1988 • 490 citations

Regulation of human eosinophil viability, density, and function by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblasts.

1987 • 408 citations

DEPOSITS OF EOSINOPHIL GRANULE PROTEINS IN CARDIAC TISSUES OF PATIENTS WITH EOSINOPHILIC ENDOMYOCARDIAL DISEASE

1987 • 291 citations

Molecular and Cellular Biology of Eosinophil Differentiation Factor (Interleukin‐5) and its Effects on Human and Mouse B Cells

1988 • 263 citations

Increased numbers of hypodense eosinophils in the blood of patients with bronchial asthma.

1985 • 215 citations

Heterogeneity of Human Peripheral Blood Eosinophils: Variability in Cell Density and Cytotoxic Ability in Relation to the Level and the Origin of Hypereosinophilia

1983 • 197 citations

Altered density, metabolism and surface receptors of eosinophils in eosinophilia.

1982 • 155 citations

Synthesis and release of leukotriene C4 by human eosinophils.

1987 • 110 citations

Characterization of a human eosinophil proteoglycan, and augmentation of its biosynthesis and size by interleukin 3, interleukin 5, and granulocyte/macrophage colony stimulating factor.

1988 • 98 citations

Release of Leukotriene C<sub>4</sub> from Human Eosinophils and its Relation to the Cell Density

1985 • 94 citations

Production of a monoclonal antibody useful in the molecular characterization of murine T-cell-replacing factor/B-cell growth factor II.

1987 • 88 citations

Eosinophil kinetics in the hypereosinophilic syndrome.

1976 • 51 citations